Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

High Magnesium Intake May Offset Risk of Developing Diabetes

Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk....
Advertisement

In this study, Hurby et al examined 7-yr associations between magnesium intake and the incidence of prediabetes and/or insulin resistance, and progression from these states to type 2 diabetes. A total of 2,582 participants ages 26–81 years old at baseline were selected. Magnesium intake and risk of metabolic impairment, defined as impaired fasting glucose (≥5.6–<7.0 mmol/L), impaired glucose tolerance (2-hr postload glucose ≥7.8–<11.1 mmol/L), insulin resistance, or hyperinsulinemia (≥90th percentile of HOMA-IR or fasting insulin, respectively), was estimated among those with normal baseline status. The risk of incident diabetes was estimated among those with baseline metabolic impairment. In participants without incident diabetes, the authors examined magnesium intake in relation to 7-yr changes in fasting and postload glucose and insulin, insulin resistance, and insulin sensitivity.

After adjusting for age, sex, and energy intake, compared to those with the lowest magnesium intake, those with the highest intake had 37% lower risk of incident metabolic impairment. For those with baseline metabolic impairment, higher intake was associated with a 32% lower risk of incident diabetes. In the combined population, the risk in those with the highest intake was 53% compared to those with the lowest intake of magnesium. Adjusting for risk factors and dietary fiber attenuated associations in the baseline normal population, but did not substantially affect associations in the metabolically impaired.

Higher magnesium intake tended to associate with lower follow-up fasting glucose and IR, but not fasting insulin, postload values, or insulin sensitivity. As a result, the authors concluded that magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.

Practice Pearls:
  • Magnesium intake may be particularly beneficial in offsetting risk of developing diabetes among those at high risk.
  • Those with the highest intake had 37% lower risk of incident metabolic impairment.

Diabetes Care, October 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 25 October, 2013 and appeared in  DietMedicationType 2 DiabetesPrediabetesIssue 700

Past five issues: Issue 766 | Diabetes Clinical Mastery Series Issue 225 | Issue 765 | Diabetes Clinical Mastery Series Issue 224 | Issue 764 |

2015 Most Popular Articles:

Significant Weight Loss and Drop in A1c with New Combo of Lorcaserin and Phentermine
Posted January 16, 2015
ADA Issues New Standards of Medical Care for Diabetes
Posted January 02, 2015
New Guideline Released on Pharmacological Management of Obesity
Posted January 23, 2015
For Your Patients: Practical Advice to Rev Up Your Workouts and Lower Fatigue
Posted January 09, 2015
Dr. Timothy Garvey on Qsymia and Other New Therapies for Weight Loss
Posted January 12, 2015
Phentermine and Topirimate ER (Qsymia) Studied for Type 2 Diabetes Patients
Posted January 15, 2015
Handbook of Diabetes, 4th Ed., Excerpt #25: Specific Circumstances that Affect Diabetes Control
Posted January 04, 2015
New Insulin Glargine 300 Effective in Type 1 Diabetes
Posted January 16, 2015
FDA Approves Maestro Electronic Weight Loss Device
Posted January 23, 2015
New Guidelines Recommend Off-Loading to Increase Likelihood of Diabetic Foot Ulcer Healing
Posted December 26, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Will you prescribe inhaled insulin (Afrezza) when it becomes available this year?
CME/CE of the Week
Hope Warshaw, MMSc, RD, CDE

Category: Nutrition
Credits: 1.25
Search Articles On Diabetes In Control